Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety.

MLA

Marousi, S., et al. “Immune Cells after Prolonged Natalizumab Therapy: Implications for Effectiveness and Safety.” Acta Neurologica Scandinavica, vol. 128, no. 1, July 2013, pp. e1–5. EBSCOhost, https://doi.org/10.1111/ane.12080.

APA

Marousi, S., Karkanis, I., Kalamatas, T., Travasarou, M., Paterakis, G., & Karageorgiou, C. E. (2013). Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety. Acta Neurologica Scandinavica, 128(1), e1–e5. https://doi.org/10.1111/ane.12080

Chicago

Marousi, S., I. Karkanis, T. Kalamatas, M. Travasarou, G. Paterakis, and C. E. Karageorgiou. 2013. “Immune Cells after Prolonged Natalizumab Therapy: Implications for Effectiveness and Safety.” Acta Neurologica Scandinavica 128 (1): e1–5. doi:10.1111/ane.12080.